30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States

SGX Pharmaceuticals Inc (SGXP)

Track

Stock chart
Ticker: SGXP
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Reich Siegfried
VP, Drug Discovery
1 sale — total 2,327 USD
Planned sale 15 Aug 2008
Value US$821,311.72 | Price 227.39 | Shares 33,496
Planned sale 5 Aug 2008
Value US$2,087,386.40 | Price 435.09 | Shares 95,647
Planned sale 15 Jul 2008
Value US$306.00 | Price 3.06 | Shares 100
Planned sale 15 Jul 2008
Value US$2,077.05 | Price 3.05 | Shares 681
Buy 11 Jul 2008
Value US$21,488.60 | Price 3.07 | Shares 7,000
Buy 11 Jul 2008
Value US$6,139.60 | Price 3.07 | Shares 2,000
Buy 11 Jul 2008
Value US$10,744.30 | Price 3.07 | Shares 3,500
Buy 10 Jul 2008
Value US$715,032.80 | Price 3.03 | Shares 236,000
Buy 10 Jul 2008
Value US$206,026.40 | Price 3.03 | Shares 68,000
Buy 10 Jul 2008
Value US$300,556.16 | Price 3.03 | Shares 99,200
Buy 9 Jul 2008
Value US$1,423,422.00 | Price 3.04 | Shares 468,000
Buy 9 Jul 2008
Value US$410,602.50 | Price 3.04 | Shares 135,000
Buy 9 Jul 2008
Value US$600,087.95 | Price 3.04 | Shares 197,300
Buy 8 Jul 2008
Value US$143,707.20 | Price 2.99 | Shares 48,000
Buy 8 Jul 2008
Value US$41,914.60 | Price 2.99 | Shares 14,000
Buy 8 Jul 2008
Value US$60,177.39 | Price 2.99 | Shares 20,100
Planned sale 7 Jul 2008
Value US$1,249.60 | Price 1.60 | Shares 781
Buy 18 Jun 2008
Value US$933,800.00 | Price 1.45 | Shares 644,000
Buy 18 Jun 2008
Value US$271,150.00 | Price 1.45 | Shares 187,000
Buy 18 Jun 2008
Value US$397,672.65 | Price 1.45 | Shares 274,257
Planned sale 16 Jun 2008
Value US$1,288.65 | Price 1.65 | Shares 781
Planned sale 5 Jun 2008
Value US$1,054.35 | Price 1.35 | Shares 781
Planned sale 15 May 2008
Value US$1,132.45 | Price 1.45 | Shares 781
Planned sale 5 May 2008
Value US$1,116.83 | Price 1.43 | Shares 781
Planned sale 15 Apr 2008
Value US$572.39 | Price 1.19 | Shares 481
Planned sale 15 Apr 2008
Value US$357.00 | Price 1.19 | Shares 300
Planned sale 7 Apr 2008
Value US$365.30 | Price 1.30 | Shares 281
Planned sale 7 Apr 2008
Value US$268.00 | Price 1.34 | Shares 200
Planned sale 7 Apr 2008
Value US$272.00 | Price 1.36 | Shares 200
Planned sale 7 Apr 2008
Value US$137.00 | Price 1.37 | Shares 100
Planned sale 17 Mar 2008
Value US$3,131.81 | Price 4.01 | Shares 781
Planned sale 5 Mar 2008
Value US$3,163.05 | Price 4.05 | Shares 781
Planned sale 15 Feb 2008
Value US$3,163.05 | Price 4.05 | Shares 781
Planned sale 5 Feb 2008
Value US$3,436.40 | Price 4.40 | Shares 781
Planned sale 15 Jan 2008
Value US$3,467.64 | Price 4.44 | Shares 781
Planned sale 7 Jan 2008
Value US$4,022.15 | Price 5.15 | Shares 781
Planned sale 17 Dec 2007
Value US$3,709.75 | Price 4.75 | Shares 781
Planned sale 5 Dec 2007
Value US$3,787.85 | Price 4.85 | Shares 781
Planned sale 15 Nov 2007
Value US$3,983.10 | Price 5.10 | Shares 781
Planned sale 5 Nov 2007
Value US$5,076.50 | Price 6.50 | Shares 781
Planned sale 15 Oct 2007
Value US$2,572.00 | Price 6.43 | Shares 400
Planned sale 15 Oct 2007
Value US$1,284.00 | Price 6.42 | Shares 200
Planned sale 15 Oct 2007
Value US$1,160.21 | Price 6.41 | Shares 181
Planned sale 5 Oct 2007
Value US$4,842.20 | Price 6.20 | Shares 781
Planned sale 17 Sep 2007
Value US$4,842.20 | Price 6.20 | Shares 781
Planned sale 5 Sep 2007
Value US$128.10 | Price 6.10 | Shares 21
Planned sale 5 Sep 2007
Value US$1,220.00 | Price 6.10 | Shares 200
Planned sale 5 Sep 2007
Value US$3,472.00 | Price 6.20 | Shares 560
Planned sale 15 Aug 2007
Value US$722.40 | Price 6.45 | Shares 112
Planned sale 15 Aug 2007
Value US$4,281.60 | Price 6.40 | Shares 669
Planned sale 6 Aug 2007
Value US$1,187.36 | Price 6.56 | Shares 181
Planned sale 6 Aug 2007
Value US$4,020.00 | Price 6.70 | Shares 600
Planned sale 16 Jul 2007
Value US$4,725.05 | Price 6.05 | Shares 781
Planned sale 5 Jul 2007
Value US$4,162.73 | Price 5.33 | Shares 781
Planned sale 15 Jun 2007
Value US$518.00 | Price 5.18 | Shares 100
Planned sale 15 Jun 2007
Value US$515.00 | Price 5.15 | Shares 100
Planned sale 15 Jun 2007
Value US$2,968.91 | Price 5.11 | Shares 581
Planned sale 5 Jun 2007
Value US$4,139.30 | Price 5.30 | Shares 781
Planned sale 15 May 2007
Value US$1,040.00 | Price 5.20 | Shares 200
Planned sale 15 May 2007
Value US$519.00 | Price 5.19 | Shares 100
Planned sale 15 May 2007
Value US$518.00 | Price 5.18 | Shares 100
Planned sale 15 May 2007
Value US$1,969.77 | Price 5.17 | Shares 381
Planned sale 7 May 2007
Value US$1,427.48 | Price 5.08 | Shares 281
Planned sale 7 May 2007
Value US$2,500.00 | Price 5.00 | Shares 500
Planned sale 16 Apr 2007
Value US$1,018.08 | Price 5.04 | Shares 202
Planned sale 16 Apr 2007
Value US$1,004.00 | Price 5.02 | Shares 200
Planned sale 16 Apr 2007
Value US$1,898.79 | Price 5.01 | Shares 379
Planned sale 5 Apr 2007
Value US$3,600.41 | Price 4.61 | Shares 781
Planned sale 15 Mar 2007
Value US$553.00 | Price 5.53 | Shares 100
Planned sale 15 Mar 2007
Value US$3,765.93 | Price 5.53 | Shares 681
Planned sale 5 Mar 2007
Value US$3,772.23 | Price 4.83 | Shares 781
Planned sale 15 Feb 2007
Value US$4,186.16 | Price 5.36 | Shares 781
Planned sale 5 Feb 2007
Value US$3,045.90 | Price 3.90 | Shares 781
Planned sale 16 Jan 2007
Value US$32,812.50 | Price 3.50 | Shares 9,375
Planned sale 5 Jan 2007
Value US$487.50 | Price 3.25 | Shares 150
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2008-08-18 2008-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
33,496 -3.5%
227.39
US$821,312 		33,496 -3.5% 227.39 US$821,312
2008-08-06 2008-08-05 PlS Planned sale Myers W Todd

CFO

Officer
95,647 -27.8%
435.09
US$2,087,386 		95,647 -27.8% 435.09 US$2,087,386
2008-07-16 2008-07-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
91,324 +14.9%
53.21
US$51,004 		91,324 +14.9% 53.21 US$51,004
2008-07-16 2008-07-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
681 -2.8%
3.05
US$2,077 		681 -2.8% 3.05 US$2,077
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
7,000 +0.1%
3.07
US$21,489 		7,000 +0.1% 3.07 US$21,489
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
2,000 +0.0%
3.07
US$6,140 		2,000 +0.0% 3.07 US$6,140
2008-07-11 2008-07-11 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
3,500 +0.1%
3.07
US$10,744 		3,500 +0.1% 3.07 US$10,744
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
236,000 +4.5%
3.03
US$715,033 		236,000 +4.5% 3.03 US$715,033
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
68,000 +1.3%
3.03
US$206,026 		68,000 +1.3% 3.03 US$206,026
2008-07-11 2008-07-10 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
99,200 +1.9%
3.03
US$300,556 		99,200 +1.9% 3.03 US$300,556
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
468,000 +10.1%
3.04
US$1,423,422 		468,000 +10.1% 3.04 US$1,423,422
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
135,000 +3.0%
3.04
US$410,602 		135,000 +3.0% 3.04 US$410,602
2008-07-11 2008-07-09 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
197,300 +4.6%
3.04
US$600,088 		197,300 +4.6% 3.04 US$600,088
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
48,000 +1.1%
2.99
US$143,707 		48,000 +1.1% 2.99 US$143,707
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
14,000 +0.3%
2.99
US$41,915 		14,000 +0.3% 2.99 US$41,915
2008-07-11 2008-07-08 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
20,100 +0.5%
2.99
US$60,177 		20,100 +0.5% 2.99 US$60,177
2008-07-07 2008-07-07 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.1%
1.60
US$1,250 		781 -3.1% 1.60 US$1,250
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
644,000 +18.1%
1.45
US$933,800 		644,000 +18.1% 1.45 US$933,800
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
187,000 +5.5%
1.45
US$271,150 		187,000 +5.5% 1.45 US$271,150
2008-06-20 2008-06-18 B Purchase BVF PARTNERS L P/IL

Indirect Beneficial Owner

Large shareholder
274,257 +8.8%
1.45
US$397,673 		274,257 +8.8% 1.45 US$397,673
2008-06-17 2008-06-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.3%
1.65
US$1,289 		781 -3.3% 1.65 US$1,289
2008-06-06 2008-06-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.2%
1.35
US$1,054 		781 -3.2% 1.35 US$1,054
2008-05-15 2008-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.4%
1.45
US$1,132 		781 -3.4% 1.45 US$1,132
2008-05-06 2008-05-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.3%
1.43
US$1,117 		781 -3.3% 1.43 US$1,117
2008-04-16 2008-04-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
481 -2.2%
1.19
US$572 		481 -2.2% 1.19 US$572
2008-04-16 2008-04-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
300 -1.4%
1.19
US$357 		300 -1.4% 1.19 US$357
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
281 -1.3%
1.30
US$365 		281 -1.3% 1.30 US$365
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
200 -0.9%
1.34
US$268 		200 -0.9% 1.34 US$268
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
200 -0.9%
1.36
US$272 		200 -0.9% 1.36 US$272
2008-04-08 2008-04-07 PlS Planned sale Myers W Todd

CFO

Officer
100 -0.4%
1.37
US$137 		100 -0.4% 1.37 US$137
2008-03-18 2008-03-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.7%
4.01
US$3,132 		781 -3.7% 4.01 US$3,132
2008-03-05 2008-03-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.6%
4.05
US$3,163 		781 -3.6% 4.05 US$3,163
2008-02-19 2008-02-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -3.8%
4.05
US$3,163 		781 -3.8% 4.05 US$3,163
2008-02-05 2008-02-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.7%
4.40
US$3,436 		781 -3.7% 4.40 US$3,436
2008-01-16 2008-01-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.0%
4.44
US$3,468 		781 -4.0% 4.44 US$3,468
2008-01-07 2008-01-07 PlS Planned sale Myers W Todd

CFO

Officer
781 -3.8%
5.15
US$4,022 		781 -3.8% 5.15 US$4,022
2007-12-18 2007-12-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.2%
4.75
US$3,710 		781 -4.2% 4.75 US$3,710
2007-12-05 2007-12-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.0%
4.85
US$3,788 		781 -4.0% 4.85 US$3,788
2007-11-16 2007-11-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.3%
5.10
US$3,983 		781 -4.3% 5.10 US$3,983
2007-11-05 2007-11-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.2%
6.50
US$5,076 		781 -4.2% 6.50 US$5,076
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
400 -2.4%
6.43
US$2,572 		400 -2.4% 6.43 US$2,572
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.2%
6.42
US$1,284 		200 -1.2% 6.42 US$1,284
2007-10-15 2007-10-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
181 -1.1%
6.41
US$1,160 		181 -1.1% 6.41 US$1,160
2007-10-05 2007-10-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -4.3%
6.20
US$4,842 		781 -4.3% 6.20 US$4,842
2007-09-17 2007-09-17 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -4.8%
6.20
US$4,842 		781 -4.8% 6.20 US$4,842
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
21 -0.1%
6.10
US$128 		21 -0.1% 6.10 US$128
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
200 -1.2%
6.10
US$1,220 		200 -1.2% 6.10 US$1,220
2007-09-05 2007-09-05 PlS Planned sale Myers W Todd

CFO

Officer
560 -3.3%
6.20
US$3,472 		560 -3.3% 6.20 US$3,472
2007-08-16 2007-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
112 -0.7%
6.45
US$722 		112 -0.7% 6.45 US$722
2007-08-16 2007-08-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
669 -4.3%
6.40
US$4,282 		669 -4.3% 6.40 US$4,282
2007-08-07 2007-08-06 PlS Planned sale Myers W Todd

CFO

Officer
181 -1.1%
6.56
US$1,187 		181 -1.1% 6.56 US$1,187
2007-08-07 2007-08-06 PlS Planned sale Myers W Todd

CFO

Officer
600 -3.7%
6.70
US$4,020 		600 -3.7% 6.70 US$4,020
2007-07-16 2007-07-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -5.3%
6.05
US$4,725 		781 -5.3% 6.05 US$4,725
2007-07-09 2007-07-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.0%
5.33
US$4,163 		781 -5.0% 5.33 US$4,163
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.7%
5.18
US$518 		100 -0.7% 5.18 US$518
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.7%
5.15
US$515 		100 -0.7% 5.15 US$515
2007-06-19 2007-06-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
581 -4.1%
5.11
US$2,969 		581 -4.1% 5.11 US$2,969
2007-06-05 2007-06-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.3%
5.30
US$4,139 		781 -5.3% 5.30 US$4,139
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.6%
5.20
US$1,040 		200 -1.6% 5.20 US$1,040
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.8%
5.19
US$519 		100 -0.8% 5.19 US$519
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.8%
5.18
US$518 		100 -0.8% 5.18 US$518
2007-05-16 2007-05-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
381 -2.9%
5.17
US$1,970 		381 -2.9% 5.17 US$1,970
2007-05-08 2007-05-07 PlS Planned sale Myers W Todd

CFO

Officer
281 -2.1%
5.08
US$1,427 		281 -2.1% 5.08 US$1,427
2007-05-08 2007-05-07 PlS Planned sale Myers W Todd

CFO

Officer
500 -3.6%
5.00
US$2,500 		500 -3.6% 5.00 US$2,500
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
202 -1.7%
5.04
US$1,018 		202 -1.7% 5.04 US$1,018
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
200 -1.7%
5.02
US$1,004 		200 -1.7% 5.02 US$1,004
2007-04-17 2007-04-16 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
379 -3.0%
5.01
US$1,899 		379 -3.0% 5.01 US$1,899
2007-04-05 2007-04-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -5.9%
4.61
US$3,600 		781 -5.9% 4.61 US$3,600
2007-03-15 2007-03-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
100 -0.9%
5.53
US$553 		100 -0.9% 5.53 US$553
2007-03-15 2007-03-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
681 -5.8%
5.53
US$3,766 		681 -5.8% 5.53 US$3,766
2007-03-05 2007-03-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -6.2%
4.83
US$3,772 		781 -6.2% 4.83 US$3,772
2007-02-15 2007-02-15 PlS Planned sale Reich Siegfried

VP, Drug Discovery

Officer
781 -7.1%
5.36
US$4,186 		781 -7.1% 5.36 US$4,186
2007-02-05 2007-02-05 PlS Planned sale Myers W Todd

CFO

Officer
781 -6.7%
3.90
US$3,046 		781 -6.7% 3.90 US$3,046
2007-01-16 2007-01-16 PlS Planned sale Reich Siegfried

Vice President, Drug Discovery

Officer
9,375 -50.0%
3.50
US$32,812 		9,375 -50.0% 3.50 US$32,812
2007-01-08 2007-01-05 PlS Planned sale Myers W Todd

Chief Financial Officer

Officer
150 -1.5%
3.25
US$488 		150 -1.5% 3.25 US$488
Explore more

More insider trading research around SGX Pharmaceuticals Inc

More insider trades in United States
Insider trading in North America